Development and validation of an UPLC-ESI-MS/MS method for quantification of duvelisib in plasma: application to pharmacokinetic study in rats

Ibrahim A. Darwish,Nourah Z. Alzoman,Aliyah Almomen,Abdulrahman A. Almehizia,Mohamed W. Attwa,Hany W. Darwish,Ahmed Y. Sayed
DOI: https://doi.org/10.1039/d3ra00310h
IF: 4.036
2023-01-01
RSC Advances
Abstract:Duvelisib (DUV) is a new oral phosphoinositide-3-kinase (PI3K)-δ and PI3K-γ inhibitor.
chemistry, multidisciplinary
What problem does this paper attempt to address?